scholarly article | Q13442814 |
P50 | author | Darren R Feldman | Q56588360 |
Daniel M Tennenbaum | Q57543592 | ||
P2093 | author name string | Maria E Arcila | |
Jonathan A Coleman | |||
Almedina Redzematovic | |||
Paul Russo | |||
James J Hsieh | |||
Martin H Voss | |||
Robert J Motzer | |||
Nicole E Benfante | |||
Maria I Carlo | |||
Abraham Ari Hakimi | |||
Brandon J Manley | |||
Jozefina Casuscelli | |||
Maria F Becerra | |||
Nabeela Khan | |||
Emily Zabor | |||
P2860 | cites work | Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response. | Q39445282 |
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling | Q42737907 | ||
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. | Q43455466 | ||
Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. | Q43806776 | ||
A clear picture of renal cell carcinoma | Q45674698 | ||
Variation in genomic landscape of clear cell renal cell carcinoma across Europe. | Q51019551 | ||
Prognostic Value of SETD2 Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors. | Q54170263 | ||
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. | Q55122666 | ||
Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up | Q88555345 | ||
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation | Q27852038 | ||
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network | Q27852242 | ||
Comprehensive molecular characterization of clear cell renal cell carcinoma | Q27852374 | ||
Integrated molecular analysis of clear-cell renal cell carcinoma | Q27852382 | ||
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study | Q33510317 | ||
BAP1 loss defines a new class of renal cell carcinoma | Q34280223 | ||
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma | Q34293726 | ||
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology | Q35584856 | ||
Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC). | Q35814190 | ||
The Global Burden of Cancer 2013 | Q35847426 | ||
Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma | Q36365688 | ||
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma | Q36373524 | ||
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma | Q36736210 | ||
VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy | Q37393004 | ||
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression. | Q37573538 | ||
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies | Q38545726 | ||
P433 | issue | 8 | |
P921 | main subject | renal cell carcinoma | Q1164529 |
P304 | page(s) | 532.e7-532.e13 | |
P577 | publication date | 2017-04-10 | |
P1433 | published in | Urologic Oncology | Q2113446 |
P1476 | title | Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy | |
P478 | volume | 35 |
Q92412551 | Combining molecular and imaging metrics in cancer: radiogenomics |
Q92372097 | Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice |
Q92154621 | Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma |
Q90319417 | Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma |
Q64977645 | Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma. |
Search more.